Volume 145, Issue 1, Pages (April 2017)

Slides:

Advertisements

Similar presentations

Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer C.E. Henry, C. Emmanuel, N.

Advertisements

Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.

EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma Maria I. Toki, MD,

Daniel Weber, David McCarthy, Jay Pathmanathan

Adeno-associated Virus Serotype Vectors Efficiently Transduce Normal Prostate Tissue and Prostate Cancer Cells Jianzhong Ai, Dan Wang, Qiang Wei, Hong.

Volume 150, Issue 1, Pages (July 2018)

3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis Perla Pérez-Treviño, Héctor Hernández-De.

Are patients willing to travel for better ovarian cancer care?

L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L

Volume 146, Issue 3, Pages (September 2017)

Volume 150, Issue 3, Pages (September 2018)

Volume 145, Issue 2, Pages (May 2017)

Volume 145, Issue 3, Pages (June 2017)

Volume 141, Issue 1, Pages 2-9 (April 2016)

Long term consumption of flaxseed enriched diet decreased ovarian cancer incidence and prostaglandin E2 in hens Erfan Eilati, Janice M. Bahr, Dale Buchanan.

The efficacy of mTORC1/2 inhibition on ovarian cancer stem cells

Volume 141, Issue 2, Pages (May 2016)

Vamsidhar Velcheti, MD, David L. Rimm, MD, PhD, Kurt A

Volume 135, Issue 1, Pages (October 2014)

M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns

A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study Vivian E. von Gruenigen,

Transforming Growth Factor-β1 Mechanisms in Aortic Valve Calcification: Increased Alkaline Phosphatase and Related Events Jocelyn N. Clark-Greuel, PhD,

Epidermal Desmoglein 1 Expression Is Reduced in Kidney Transplant Recipients Compared with Immunocompetent Patients Jodi L. Johnson, Paul Hoover, Borko.

Volume 148, Issue 1, Pages (January 2018)

Volume 136, Issue 2, Pages (February 2015)

Volume 145, Issue 2, Pages (May 2017)

Volume 130, Issue 3, Pages (September 2013)

L.M. Bean, F.J. Sulzmaier, D.D. Schlaepfer

National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence J. Chino, J.R. Foote,

Volume 151, Issue 1, Pages (October 2018)

Volume 151, Issue 1, Pages (October 2018)

K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani

Volume 152, Issue 1, Pages (January 2019)

Volume 147, Issue 2, Pages (November 2017)

Volume 152, Issue 1, Pages (January 2019)

Volume 143, Issue 2, Pages (November 2016)

Adherence to hematologic hold parameters in dose-dense chemotherapy for ovarian malignancies: A survey of the National Comprehensive Cancer Network (NCCN)

I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M

Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum A. Ellis, M.K. Frey, L.M. Koontz, S. Shyne,

Volume 152, Issue 1, Pages (January 2019)

Volume 150, Issue 1, Pages (July 2018)

Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates N.A. Latif, E.M. Ko,

Jean-Emmanuel Bibault, Ingeborg Tinhofer

NF-κB Dynamics Discriminate between TNF Doses in Single Cells

Volume 147, Issue 1, Pages (October 2017)

Volume 96, Issue 8, Pages (April 2009)

Dexmedetomidine pharmacokinetic–pharmacodynamic modelling in healthy volunteers: 1. Influence of arousal on bispectral index and sedation P.J. Colin,

Volume 153, Issue 1, Pages (April 2019)

Volume 142, Issue 2, Pages (August 2016)

Annika Idahl, Andrea Hermansson, Ann Lalos Gynecologic Oncology

Volume 147, Issue 3, Pages (December 2017)

Volume 150, Issue 3, Pages (September 2018)

Ly6/uPAR-Related Protein C4

Volume 152, Issue 1, Pages (January 2019)

Volume 130, Issue 3, Pages (September 2013)

Volume 151, Issue 1, Pages (October 2018)

Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer M. Dandapani, B.L. Seagle, R. Samuelson,

Volume 130, Issue 1, Pages (July 2013)

Volume 142, Issue 3, Pages (September 2016)

Organization news Archives of Physical Medicine and Rehabilitation

Erratum to “Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma” [Gynecol Oncol. 120 (2011) 11–17] Heini Lassus,

Characteristics of primary peritoneal serous carcinoma in a U. S

Volume 11, Issue 3, Pages (April 2015)

Volume 147, Issue 3, Pages (December 2017)

Volume 154, Issue 1, Pages (July 2019)

Should ovarian preservation be considered for women younger than 60 years with endometrial carcinoma? L.M. Bean, K. Taylor, K.M. Anderson, M.A. Davis,

Editorial Board Orthopedic Clinics Volume 47, Issue 2, (April 2016)

A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study Vivian E. von Gruenigen,

Volume 50, Issue 2, Pages iii-iv (April 2019)

Volume 154, Issue 2, Pages (August 2019)

Presentation transcript:

Volume 145, Issue 1, Pages 154-158 (April 2017) Objective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significance Daniel E. Carvajal-Hausdorf, Kurt A. Schalper, Yalai Bai, Jonathan Black, Alessandro D. Santin, David L. Rimm Gynecologic Oncology Volume 145, Issue 1, Pages 154-158 (April 2017) DOI: 10.1016/j.ygyno.2017.02.002 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 HER2 intracellular (ICD) and extracellular (ECD) domain measurement in uterine (USC) and ovarian serous carcinomas (OSC). Bar plots show the distribution of scores for HER2 ICD/ECD in USC (A, C) and in OSC (B, D). Panels E and F depict ECD vs ICD scatterplots in USC and OSC, respectively. Red dotted line: median. QIF: quantitative immunofluorescence. AU: arbitrary units of fluorescence. Gynecologic Oncology 2017 145, 154-158DOI: (10.1016/j.ygyno.2017.02.002) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 Domain-specific detection of HER2 in USC and OSC. Representative fluorescent microphotographs showing different patterns of HER2 ICD/ECD expression in human USC (left panels) and OSC (right panels). Blue channel: 4,6-diamidino-2-phenylindole; red channel: HER2 ICD/ECD. Bar: 100μm. Gynecologic Oncology 2017 145, 154-158DOI: (10.1016/j.ygyno.2017.02.002) Copyright © 2017 The Authors Terms and Conditions